LobbyingCure Alzheimer's Fund lobbying by quarter
Cure Alzheimer's Fund's latest lobbying report covers Q4 2024, at $20K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.
Cure Alzheimer's Fund
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$90K · 9 reports
- Medical research and clinical labs$90K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- Natl Institutes of Health (NIH)9 reports
- SENATE9 reports
- Environmental Protection Agency (EPA)5 reports
- Centers For Medicare and Medicaid Services (CMS)3 reports
- Food & Drug Administration (FDA)1 reports
- Office of Management & Budget (OMB)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Francis Edward & Cronin | $180K | 9 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/01for Q4 2024 | Francis Edward & Cronin | $20K |
| 24/10/04for Q3 2024 | Francis Edward & Cronin | $20K |
| 24/07/04for Q2 2024 | Francis Edward & Cronin | $20K |
| 24/03/31for Q1 2024 | Francis Edward & Cronin | $20K |
| 24/01/01for Q4 2023 | Francis Edward & Cronin | $20K |
| 23/10/01for Q3 2023 | Francis Edward & Cronin | $20K |
| 23/07/01for Q2 2023 | Francis Edward & Cronin | $20K |
| 23/04/01for Q1 2023 | Francis Edward & Cronin | $20K |
| 23/01/01for Q4 2022 | Francis Edward & Cronin | $20K |